Eli Lilly (LLY) PT Lowered to $1,190 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,280.00 +0.51%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 20 | New: 41
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 20 | New: 41
Join SI Premium – FREE
Citi analyst Geoff Meacham lowered the price target on Eli Lilly (NYSE: LLY) to $1,190.00 (from $1,250.00) while maintaining a Buy rating.
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,450 at Bernstein SocGen on 'International Upside Potential'
- Lilly declares fourth-quarter 2026 dividend
- Customers Bancorp (CUBI) PT Raised to $97 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
